PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Business

Mitsui Chemicals to Acquire JSR With Development Bank of Japan for $8.8 Billion

Mitsui Chemicals has agreed to buy semiconductor materials maker JSR for about 1.84 trillion yen ($11.6 billion), with the Development Bank of Japan taking a stake.

11sources
14articles
15velocity
+433%since first seen
8d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Mitsui Chemicals planned to acquire semiconductor material manufacturer JSR to bolster Japan's chip industry. Following reports of the multi-billion-dollar acquisition, Mitsui Chemicals' shares fell, with commentary noting that the buyer did not benefit from the deal. The story quieted without a definitive conclusion in the coverage regarding the finalization of the transaction.

Epilogue added 6d ago, after coverage quieted.

The brief

Mitsui Chemicals has agreed to acquire JSR Corp., a producer of photoresists used in chipmaking, in a transaction valued at approximately 1.84 trillion yen ($11.6 billion), PYMNTS.com reported. The deal, announced Monday, involves Japan's state-backed Development Bank of Japan, which will contribute 200 billion yen for an ownership interest that will later be converted into non-voting preferred shares, according to Reuters.

The transaction transfers JSR from the government-backed Japan Investment Corp. (JIC) to Mitsui Chemicals, giving the chemical maker control of a supplier of specialized materials for advanced semiconductor production. JIC acquired JSR for some 900 billion yen two years ago and had said it planned to use the business to drive consolidation in the semiconductor materials sector, Reuters reported. The fund is selling as chip-related valuations rise on a boom in AI investment.

JSR, established in 1957, is a leading manufacturer of photoresists, the light-sensitive chemicals used to transfer circuit patterns onto semiconductor wafers. Mitsui Chemicals is also expanding its chip materials business. The deal is expected to be the largest in Japan's chemicals sector, surpassing Showa Denko's $4.55 billion purchase of Hitachi Chemical in 2020, which created Resonac Holdings, Reuters reported.

Financing is the central concern. Mitsui Chemicals plans to secure a 1.64 trillion yen bridge loan and issue as much as 150 billion yen in new shares, with additional funding from bank borrowing, debt securities and mezzanine capital, according to Reuters. The company had 217.8 billion yen in cash and cash equivalents and 876.4 billion yen in interest-bearing debt as of the end of June, Reuters reported. Based on Friday's closing price, its market capitalization was approximately 664.6 billion yen, according to London Stock Exchange Group data cited by Reuters.

Shares of Mitsui Chemicals declined 8.5% on Monday, extending losses after Reuters identified the company as the prospective buyer the previous week, PYMNTS.com reported. "Concern about the substantial amount of funding needed appear to have come to the fore," said Tsutomu Yamada, an analyst at Mitsubishi UFJ eSmart Securities, of the share fall. Yamada said adding JSR's semiconductor strengths could boost Mitsui's presence in the sector and lead to a re-rating.

Mitsui Chemicals Chief Executive Officer Satoshi Ichimura described the transaction as part of a broader effort to reshape the company's business portfolio rather than simply increase its presence in semiconductor materials, according to Reuters. The company expects the combination to generate an additional 40 billion yen in annual profit, Reuters reported. Management plans to divest JSR's life sciences division and other operations outside the combined company's core strategy, and aims to restore a financially sound position within three years through restructuring and other measures.

Shogo Ikeuchi, chief executive of JIC Capital, cautioned that combining complementary product portfolios would not automatically produce substantial synergies, according to Reuters. He nevertheless indicated that closer cooperation could support technological development and long-term expansion. The deal comes as Japan seeks to strengthen its position in semiconductor supply chains; Akira Minamikawa, an analyst at Omdia, said the materials market is growing, particularly thanks to AI, and that companies remaining small will be unable to address it.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 7d ago.

Quick answers

How much is Mitsui Chemicals paying for JSR?

The transaction is valued at approximately 1.84 trillion yen ($11.6 billion), according to PYMNTS.com. Reuters earlier reported the deal could exceed 1.3 trillion yen ($8.20 billion).

What is JSR and why is it valuable to Mitsui Chemicals?

JSR, established in 1957, is a leading manufacturer of photoresists, the light-sensitive chemicals used to transfer circuit patterns onto semiconductor wafers, Reuters reported. Mitsui Chemicals is also expanding its chip materials business, and the company expects the combination to generate an additional 40 billion yen in annual profit, according to Reuters.

How will Mitsui Chemicals finance the JSR acquisition?

According to Reuters, the company plans to secure a 1.64 trillion yen bridge loan and issue as much as 150 billion yen in new shares. Additional financing will include bank borrowing, debt securities and mezzanine capital. Mitsui Chemicals had 217.8 billion yen in cash and cash equivalents and 876.4 billion yen in interest-bearing debt as of the end of June.

Why did Mitsui Chemicals shares fall after the deal?

Shares declined 8.5% on Monday, extending losses after Reuters identified the company as the prospective buyer the previous week, PYMNTS.com reported. Tsutomu Yamada, an analyst at Mitsubishi UFJ eSmart Securities, said concern about the substantial amount of funding needed had come to the fore.

Coverage (14)

Topics

Related trends

↑ Rising Business

AI stock optimists are holding on for dear life: Chart

Bank of America's latest fund-manager survey shows the sharpest reduction in tech allocations since 2006, yet chip-stock bets remain the market's most crowded trade.

12 sources 12 articles v 52 18h ago
\n \n \n \n \n \n \n